Xbrane Biopharma AB (XBRANE.ST) Q3 2024 Earnings

28AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-3.31
-2.22
-1.13
-0.04

Details

Expected EPS
-0.0422790129531
Actual EPS
-0.04599003249621
Surprise EPS
-0
Surprise Percent
+8.78%

Description

Xbrane Biopharma AB (XBRANE.ST) has reported earnings of -0.04599003249621 per share for Q3 2024.

0 Comments

Share your thoughts